Paucity of IL-21-producing CD4+ T cells is associated with Th17 cell depletion in SIV infection of rhesus macaques

Blood

Volumn 120, Issue 19, 2012, Pages 3925-3935

  Micci, Luca ^a   Cervasi, Barbara ^a   Ende, Zachary S ^a   Iriele, Robin I ^a   Reyes Aviles, Elane ^b   Vinton, Carol ^c   Else, James ^a   Silvestri, Guido ^a   Ansari, Aftab A ^a   Villinger, Francois ^a,d   Pahwa, Savita ^e   Estes, Jacob D ^f   Brenchley, Jason M ^c   Paiardini, Mirko ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d EMORY UNIVERSITY   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 21;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; IN VIVO STUDY; MEMORY T LYMPHOCYTE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RECTUM MUCOSA; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; TH17 CELL;

EID: 84868609542     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-04-420240     Document Type: Article

References (51)

1. Douek DC, Roederer M, Koup RA. Emerging concepts in the immunopathogenesis of AIDS. Annu Rev Med. 2009;60:471-484.
2. Giorgi JV, Hultin LE, McKeating JA, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis. 1999;179(4):859-870. (Pubitemid 29159331)
3. Deeks SG, Kitchen CM, Liu L, et al. Immune activation set point during early HIV infection predicts subsequent CD4- T-cell changes independent of viral load. Blood. 2004;104(4):942-947. (Pubitemid 39038012)
4. Hunt PW, Martin JN, Sinclair E, et al. T cell activation is associated with lower CD4- T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis. 2003;187(10):1534- 1543.
5. Chahroudi A, Bosinger SE, Vanderford TH, Paiardini M, Silvestri G. Natural SIV hosts: showing AIDS the door. Science. 2012;335(6073): 1188-1193.
6. Sodora DL, Allan JS, Apetrei C, et al. Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts. Nat Med. 2009;15(8):861-865.
7. Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol. 2010;28:445-489.
8. Klatt NR SG. CD4+ T cells and HIV: a paradoxical Pas de Deux. Sci Transl Med. 2012;4(123): 123ps4.
9. Brenchley JM, Paiardini M, Knox KS, et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood. 2008;112(7):2826-2835.
10. Paiardini M, Cervasi B, Reyes-Aviles E, et al. Low levels of SIV infection in sooty mangabey central memory CD T cells are associated with limited CCR5 expression. Nat Med. 2011;17(7):830-836.
11. Kornfeld C, Ploquin MJ, Pandrea I, et al. Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J Clin Invest. 2005; 115(4):1082-1091. (Pubitemid 40489413)
12. Cecchinato V, Trindade CJ, Laurence A, et al. Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. Mucosal Immunol. 2008;1(4):279-288. (Pubitemid 351850534)
13. Raffatellu M, Santos RL, Verhoeven DE, et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med. 2008;14(4): 421-428. (Pubitemid 351499394)
14. Dandekar S, George MD, Baumler AJ. Th17 cells, HIV and the gut mucosal barrier. Curr Opin HIV AIDS. 2010;5(2):173-178.
15. Guglani L, Khader SA. Th17 cytokines in mucosal immunity and inflammation. Curr Opin HIV AIDS. 2010;5(2):120-127.
16. Gordon SN, Cervasi B, Odorizzi P, et al. Disruption of intestinal CD4- T cell homeostasis is a key marker of systemic CD4- T cell activation in HIV-infected individuals. J Immunol. 2010;185(9): 5169-5179.
17. Estes JD, Harris LD, Klatt NR, et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog. 2010;6(8): e1001052.
18. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12(12):1365-1371. (Pubitemid 44924494)
19. Yi JS, Cox MA, Zajac AJ. Interleukin-21: a multifunctional regulator of immunity to infections. Microbes Infect. 2010;12(14):1111-1119.
20. Spolski R, Leonard WJ. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu Rev Immunol. 2008;26:57-79. (Pubitemid 351600371)
21. Barker BR, Gladstone MN, Gillard GO, Panas MW, Letvin NL. Critical role for IL-21 in both primary and memory anti-viral CD8- T-cell responses. Eur J Immunol. 2010;40(11):3085- 3096.
22. Yi JS, Ingram JT, Zajac AJ. IL-21 deficiency influences CD8 T cell quality and recall responses following an acute viral infection. J Immunol. 2010;185(8):4835-4845.
23. Chevalier MF, Julg B, Pyo A, et al. HIV-1-specific interleukin-21- CD4- T cell responses contribute to durable viral control through the modulation of HIV-specific CD8- T cell function. J Virol. 2011;85(2):733-741.
24. Zhou L, Ivanov II, Spolski R, et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol. 2007;8(9):967-974. (Pubitemid 47300011)
25. Nurieva R, Yang XO, Martinez G, et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature. 2007;448(7152): 480-483. (Pubitemid 47123514)
26. Korn T, Bettelli E, Gao W, et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature. 2007;448(7152):484-487. (Pubitemid 47123515)
27. Yang L, Anderson DE, Baecher-Allan C, et al. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature. 2008; 454(7202):350-352.
28. Ozaki K, Spolski R, Feng CG, et al. A critical role for IL-21 in regulating immunoglobulin production. Science. 2002;298(5598):1630-1634. (Pubitemid 35387203)
29. Ozaki K, Spolski R, Ettinger R, et al. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol. 2004;173(9):5361-5371. (Pubitemid 39392119)
30. Zotos D, Coquet JM, Zhang Y, et al. IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. J Exp Med. 2010;207(2):365-378.
31. Parrish-Novak J, Dillon SR, Nelson A, et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature. 2000;408(6808):57-63.
32. Elsaesser H, Sauer K, Brooks DG. IL-21 is required to control chronic viral infection. Science. 2009;324(5934):1569-1572.
33. Yi JS, DuM, Zajac AJ.Avital role for interleukin-21 in the control of a chronic viral infection. Science. 2009; 324(5934):1572-1576.
34. Fröhlich A, Kisielow J, Schmitz I, et al. IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science. 2009; 324(5934):1576-1580.
35. Harris LD, Klatt NR, Vinton C, et al. Mechanisms underlying gammadelta T-cell subset perturbations in SIV-infected Asian rhesus macaques. Blood. 2010;116(20):4148-4157.
36. Onlamoon N, Rogers K, Mayne AE, et al. Soluble PD-1 rescues the proliferative response of simian immunodeficiency virus-specific CD4 and CD8 T cells during chronic infection. Immunology. 2008; 124(2):277-293.4877-4885.
37. Suto A, Kashiwakuma D, Kagami S, et al. Development and characterization of IL-21-producing CD4- T cells. J Exp Med. 2008;205(6):1369- 1379.
38. Wang X, Xu H, Gill AF, et al. Monitoring alpha4beta7 integrin expression on circulating CD4- T cells as a surrogate marker for tracking intestinal CD4- T-cell loss in SIV infection. Mucosal Immunol. 2009;2(6):518-526.
39. Kader M, Wang X, Piatak M, et al. Alpha4(-) beta7(hi)CD4(-) memory T cells harbor most Th-17 cells and are preferentially infected during acute SIV infection. Mucosal Immunol. 2009; 2(5):439-449.
40. Annunziato F, Cosmi L, Santarlasci V, et al. Phenotypic and functional features of human Th17 cells. J Exp Med. 2007;204(8):1849-1861. (Pubitemid 47240944)
41. Singh SP, Zhang HH, Foley JF, Hedrick MN, Farber JM. Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. J Immunol. 2008;180(1):214-221.
42. Dunham R, Pagliardini P, Gordon S, et al. The AIDS resistance of naturally SIV-infected sooty mangabeys is independent of cellular immunity to the virus. Blood. 2006;108(1):209-217. (Pubitemid 43990631)
43. Meythaler M, Wang Z, Martinot A, et al. Early induction of polyfunctional simian immunodeficiency virus (SIV)-specific T lymphocytes and rapid disappearance of SIV from lymph nodes of sooty mangabeys during primary infection. J Immunol. 2011;186(9):5151-5161.
44. Gordon SN, Klatt NR, Bosinger SE, et al. Severe depletion of mucosal CD4- T cells in AIDS-free simian immunodeficiency virus-infected sooty mangabeys. J Immunol. 2007;179(5):3026-3034.
45. Pandrea I, Apetrei C, Gordon S, et al. Paucity of CD4-CCR5- T cells is a typical feature of natural SIV hosts. Blood. 2007;109(3):1069-1076. (Pubitemid 46220653)
46. Iannello A, Boulassel MR, Samarani S, et al. Dynamics and consequences of IL-21 production in HIV-infected individuals: a longitudinal and crosssectional study. J Immunol. 2010;184(1):114-126.
47. Yue FY, Lo C, Sakhdari A, et al. HIV-specific IL-21 producing CD4- T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral control. J Immunol. 2010; 185(1):498-506.
48. Iannello A, Samarani S, Ahmad A. Comment on "HIV-specific IL-21 producing CD4+ T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral control." J Immunol. 2010;185(10):5675; author reply 5675.
49. Favre D, Lederer S, Kanwar B, et al. Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog. 2009;5(2):e1000295.
50. Hashmi MH, Van Veldhuizen PJ. Interleukin-21: updated review of Phase I and II clinical trials in metastatic renal cell carcinoma, metastatic melanoma and relapsed/refractory indolent non- Hodgkin's lymphoma. Expert Opin Biol Ther. 2010;10(5):807-817.
51. Pallikkuth S, Rogers K, Villinger F, et al. Interleukin-21 administration to rhesus macaques chronically infected with simian immunodeficiency virus increases cytotoxic effector molecules in T cells and NK cells and enhances B cell function without increasing immune activation or viral replication. Vaccine. 2011; 29(49):9229-9238.